Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Today West Virginia.
Press releases published on July 31, 2025
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report second quarter financial results on …
authID Launches Identity Exchange (IDX) to Eliminate Enterprise Identity Blind Spots, in Strategic Partnership with NEC Networks & System Integration Corporation (NESIC)
GlobeNewswire
·
July 31, 2025
New platform delivers passwordless, privacy-first, and interoperable digital credentials to modernize identity security and support Zero Trust architecture DENVER, July 31, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID”), a leading provider of …
GigaCloud Technology Inc to Announce 2025 Second Quarter and Six Month Financial Results and Host Conference Call on August 7, 2025
GlobeNewswire
·
July 31, 2025
EL MONTE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that it will report …
Cerence AI to Participate in Two Investor Conferences in August
GlobeNewswire
·
July 31, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the company will participate in two investor conferences in August: …
Rocket Doctor’s Virtually-Enabled Emergency Department Diversion Program Reduces Strain on Overwhelmed Hospitals
GlobeNewswire
·
July 31, 2025
Virtually-enabled Emergency Department (ED) at Georgian Bay General Hospital has successfully connected over 3,000 patients with MDs,with 97.5% managed virtually and only 1% redirected to the ED. The Ontario program has saved an estimated $1.4 …
ACTFORE Secures Patent for Intelligent Data Extraction from Unstructured Documents, Revolutionizing Breach Response
GlobeNewswire
·
July 31, 2025
RESTON, Va., July 31, 2025 (GLOBE NEWSWIRE) -- ACTFORE, a leading provider of AI-powered breach response and data mining solutions, announced today the company has been granted a patent from the United States Patent and Trademark Office for its proprietary …
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 31, 2025
THE WOODLANDS, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Nasdaq’s listing qualifications staff has determined that the closing bid price of the Company’s common stock has been at $1.00 per …
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2025. “In Q2, …
VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration
GlobeNewswire
·
July 31, 2025
BENGALURU, India, July 31, 2025 (GLOBE NEWSWIRE) -- VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform, cutting drug discovery timelines in half, alongside a strategic …
Citadel Leads $50 Million Strategic Investment into Rezolve Ai to Accelerate AI-Powered Retail
GlobeNewswire
·
July 31, 2025
Institutional Conviction Capital with No Warrants or Protections Signals Long-Term Bet on Rezolve’s High-ROI Growth Path Fresh Funding Follows Major 2025 Milestones Including $70M ARR, Tier-1 Retail Wins, and Microsoft …
Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study
GlobeNewswire
·
July 31, 2025
Available data from 13 patients with recurrent, platinum resistant, ARID1a-mutated ovarian cancer treated with 75 mg/day in the NXP800 Phase 1b study includes 2 partial responses and 3 stable diseases; thrombocytopenia successfully managed with …
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 31, 2025
Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical …
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
GlobeNewswire
·
July 31, 2025
PHILADELPHIA and VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to …
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
GlobeNewswire
·
July 31, 2025
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its second quarter 2025 financial …
Kura Oncology to Report Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report second quarter …
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic
GlobeNewswire
·
July 31, 2025
CNSide available for the state of Texas in August 2025 Initial commercial focus on NCI-Designated Cancer Centers and large private healthcare systems Company will expand testing services and broaden regional availability over the next 12 months HOUSTON, …
ZenaTech’s ZenaDrone Initiates AUVSI Membership Upgrade, Enabling Leadership on Drone Policy and Strengthening US Defense and Government Engagement
GlobeNewswire
·
July 31, 2025
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Psyence BioMed’s Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production
GlobeNewswire
·
July 31, 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the production of purified psychedelic compounds – has …
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will report its second quarter 2025 …